In this articles section of The world of allergens you find news from within the industry and references to publications relevant to Allergon´s current R&D activities. Please select article to read in the column to the right.
European private equity firm Cinven signed an agreement on November 16 to acquire Phadia from PPM Capital and Triton for an enterprise value of Euro 1.285 billion.
Phadia, the parent company of Allergon, recently completed the accquisition of the Uppasala based Swedish company MIAB, a provider of allergens and a supplier to Phadia.